Audrey M. Sigmund

Audrey M. Sigmund's work focuses on blood cancers, particularly lymphoma and leukemia, with emphasis on real-world outcomes of treatments like CAR T-cell therapy, stem cell transplantation, and chemotherapy regimens for relapsed or refractory disease. Additional work addresses medical education, including curricula and mentorship programs for hematology/oncology trainees. Research draws on multicenter patient data to study comorbidities, treatment toxicity, and survival outcomes.

Publication output has grown substantially over the last decade, rising from just 1-2 papers per year around 2017-2019 to a sustained higher rate of roughly 9-17 papers annually from 2020 onward.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026